High-risk cutaneous squamous-cell carcinoma has a substantial risk of recurrence after surgery and radiotherapy. New research findings on adjuvant cemiplimab therapy are summarized in a short video.

Audio Interview from the New England Journal of Medicine — Interview with Nicholas Bagley on the Supreme Court’s decision in a case with implications for coverage of preventive services.

Many learners are more facile with the use of large language models in medicine than their supervisors are. The authors ...

In this randomized trial, the inhaled recombinant human GM-CSF molgramostim improved pulmonary gas transfer in patients with autoimmune pulmonary alveolar proteinosis.

Neoadjuvant nivolumab plus chemotherapy has previously been shown to improve pathological response in resectable non–small-cell lung cancer. New research findings on overall survival at 5 years ...

Inhaled molgramostim showed promise for treating patients with autoimmune pulmonary alveolar proteinosis in an early trial. New research findings from a phase 3 trial are summarized in a short video.

Methods In this phase 3, double-blind, placebo-controlled trial, we randomly assigned patients with aPAP to receive molgramostim at a dose of 300 μg or placebo once daily for 48 weeks. The ...

A 32-year-old woman presented with fatigue, myalgias, and palpitations. The cardiac rhythm was irregularly irregular, and an electrocardiogram showed findings suggestive of grouped beating. A diagn ...

Original Article from The New England Journal of Medicine — The Electronic Reactions of Abrams ...

The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain ...